for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

EssilorLuxottica SA

ESLX.PA

Latest Trade

106.95EUR

Change

0.80(+0.75%)

Volume

582,468

Today's Range

106.95

 - 

108.75

52 Week Range

86.76

 - 

145.00

As of on the Euronext Paris ∙ Minimum 15 minute delay

Pricing

Previous Close
106.15
Open
107.40
Volume
582,468
3M AVG Volume
11.51
Today's High
108.75
Today's Low
106.95
52 Week High
145.00
52 Week Low
86.76
Shares Out (MIL)
438.15
Market Cap (MIL)
46,447.46
Forward P/E
54.59
Dividend (Yield %)
--

Latest Developments

More

Facebook And EssilorLuxottica Announce Collaboration For Smart Glasses

GrandVision: District Court Dismisses EssilorLuxottica Claims

GrandVision Confirms EssilorLuxottica Taken Measures To Secure Certain Information

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About EssilorLuxottica SA

EssilorLuxottica SA, formerly known as Essilor International Compagnie Generale D Optique SA, is a France-based ophthalmic company. The Company designs, manufactures and markets a range of lenses, frames and sunglasses to improve and protect eyesight. It also develops and markets equipment for prescription laboratories and instruments, and services for eye care professionals. It operates through three segments: Lenses and Optical Instruments, which includes corrective lenses, optical instruments intended for opticians and optometrists; Equipment, which includes machines and consumables used by plants and prescription laboratories, and Sunglasses & Readers, which encompasses non-prescription reading glasses and non-prescription sunglasses. The Company operates under a number of brands, including Ray-Ban, Oakley and Varilux, among others. The Company operates in Europe, North America, Asia Pacific, the Middle East, Africa and Latin America.

Industry

Medical Equipment & Supplies

Contact Info

147 rue de Paris

94220

France

+33.1.49774224

https://www.essilorluxottica.com/

Executive Leadership

Leonardo Del Vecchio

Executive Chairman of the Board

Hubert Sagnieres

Executive Vice Chairman of the Board

Stefano Grassi

Co-Chief Financial Officer

David Wielemans

Co-Chief Financial Officer

Paul du Saillant

Chief Executive Officer of Essilor, Non-independent director

Key Stats

2.41 mean rating - 22 analysts
Sell
Hold
Buy
Revenue (MM, EUR)

2017

7.5K

2018

16.2K

2019

17.4K

2020(E)

14.6K
EPS (EUR)

2017

3.850

2018

4.230

2019

4.390

2020(E)

1.978
Price To Earnings (TTM)
--
Price To Sales (TTM)
3.13
Price To Book (MRQ)
1.37
Price To Cash Flow (TTM)
20.50
Total Debt To Equity (MRQ)
36.73
LT Debt To Equity (MRQ)
32.34
Return on Investment (TTM)
0.13
Return on Equity (TTM)
0.12

Latest News

Latest News

EssilorLuxottica to appeal court verdict over GrandVision

Spectacles maker EssilorLuxottica <ESLX.PA> said it would appeal against a Dutch court's verdict that had rejected its contention that takeover target GrandVision <GVNV.AS> had breached a deal agreement.

EssilorLuxottica may appeal court verdict over GrandVision

Spectacles maker EssilorLuxottica <ESLX.PA> said on Tuesday that it may appeal against an earlier court verdict regarding its planned takeover target GrandVision <GVNV.AS>, after it lost a Dutch court case which could jeopardise the deal.

EssiLux loses Dutch court case against takeover target GrandVision

EssilorLuxottica <ESLX.PA> on Monday lost a Dutch court case in which the eyewear maker was seeking to obtain more information from acquisition target GrandVision <GVNV.AS> about its management of the coronavirus crisis.

EssiLux loses Dutch court case against acquisition target GrandVision

A Dutch court on Monday denied EssilorLuxottica the right to obtain more information from its acquisition target GrandVision about its management of the coronavirus crisis.

EssiLux case puts $8.5 billion GrandVision takeover in doubt

EssilorLuxottica <ESLX.PA> said on Monday that GrandVision's <GVNV.AS> actions during the coronavirus crisis could provide grounds for ending its 7.2 billion euro ($8.5 billion) takeover of the Dutch eyewear stores operator.

EssiLux case calls $8.5 billion GrandVision bid into question

EssilorLuxottica said on Monday that GrandVision's actions during the coronavirus crisis could provide grounds for ending a 7.2 billion euro ($8.5 billion) takeover of the Dutch eyewear stores operator.

EssilorLuxottica says too early to reinstate guidance as sales halve in second quarter

Oakley and Ray-Ban maker EssilorLuxottica's <ESLX.PA> second-quarter revenue almost halved due to store closures to curb the spread of the coronavirus, it said on Friday, sending operating profit tumbling by more than 90%.

CORRECTED-EssilorLuxottica Q2 sales plummet due to store closures

Oakley and Ray-Ban eyewear maker EssilorLuxottica reported a 46% fall in second-quarter revenue on Friday, as a gradual recovery in May and June did not offset the impact of store closures to curb the spread of the coronavirus.

Dutch eyeglass store firm GrandVision seeks ruling in EssilorLuxottica case

GrandVision<GVNV.AS>, the Dutch operator of a chain of eyeglass stores, said on Thursday it had started an arbitration case against its would-be buyer EssilorLuxottica to ensure the French-Italian eyeglass firm "complies with its obligations."

EU again halts probe into EssilorLuxottica's Dutch deal

EU antitrust enforcers have temporarily halted an investigation into Ray-Ban maker EssilorLuxottica's <ESLX.PA> 7.2 billion euro ($8.34 billion) bid for Dutch optician group GrandVision, a filing on the European Commission website showed on Thursday.

Court to hear EssilorLuxottica's case against GrandVision on Aug. 10

The district court of Rotterdam on Monday said it would hear the case that EssilorLuxottica <ESLX.PA> has filed against its acquisition target GrandVision <GVNV.AS> on Aug 10.

EssiLux sues M&A target GrandVision to get information on COVID management

EssilorLuxottica <ESLX.PA> has filed a legal action to obtain information from its acquisition target GrandVision <GVNV.AS> about its management of the coronavirus crisis, the French-Italian maker of Ray-Ban said on Saturday.

EssiLux sues M&A target GrandVision to get COVID information

EssilorLuxottica has filed a legal action to obtain information from its acquisition target GrandVision about its management of the coronavirus crisis, the French-Italian maker of Ray-Ban said on Saturday.

EU decision on EssilorLuxottica's Dutch deal extended to August 27

EU antitrust authorities have extended their investigation into Ray-Ban maker EssilorLuxottica's <ESLX.PA> 7.2 billion euro ($8.2 billion) bid for Dutch opticians group GrandVision by a week to Aug. 27.

EU regulators extend probe into EssilorLuxottica's Dutch deal to August 20

EU antitrust authorities have extended their investigation into Ray-Ban maker EssilorLuxottica's <ESLX.PA> 7.2-billion-euro ($8.1 billion) bid for Dutch opticians group GrandVision by a week to Aug. 20.

EssilorLuxottica set to get EU warning about Dutch deal: sources

EU regulators are set to warn Ray-Ban maker EssilorLuxottica that its 7.2 billion euro ($8.1 billion) bid for opticians group GrandVision may harm competition, people familiar with the matter said, pressuring the group to offer concessions.

EU regulators to warn EssilorLuxottica about Dutch deal, sources say

EU antitrust regulators will warn EssilorLuxottica that its 7.2-billion-euro ($8.1 billion) bid for Dutch opticians group GrandVision could harm competition, people familiar with the matter said on Thursday.

EU regulators set new August 13 deadline for EssilorLuxottica's Dutch deal

EU antitrust regulators have set a new deadline of Aug. 13 for their decision on Ray-Ban maker EssilorLuxottica's <ESLX.PA> 7.2-billion-euro ($7.8 billion) bid for Dutch opticians group GrandVision <GVNV.AS>, a European Commission filing shows.

EssilorLuxottica sales slump on coronavirus hit, worst yet to come

Oakley and Ray-Ban maker EssilorLuxottica <ESLX.PA> reported a slump in first-quarter sales on Tuesday and warned of an even bigger hit in the current quarter as the coronavirus outbreak prompted store closures.

BRIEF-EssilorLuxottica Q1 Revenue Down 10.1% Y/Y

* GOOD RESISTANCE FOR THE FIRST QUARTER WITH REVENUE DOWN 10%, TAKING MEASURES TO CONTROL COSTS AND PRESERVE CASH & PREPARING FOR RECOVERY AND DELIVERING ON OUR RESPONSIBILITIES TO ALL

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up